The PI-3 kinase/Akt pathway and T cell activation:: pleiotropic pathways downstream of PIP3

被引:212
作者
Kane, LP [1 ]
Weiss, A [1 ]
机构
[1] Univ Calif San Francisco, Dept Med, Howard Hughes Med Inst, San Francisco, CA 94143 USA
关键词
D O I
10.1034/j.1600-065X.2003.00008.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Ligation of the T cell receptor for antigen (TCR) and/or costimulatory receptor CD28 results in rapid activation of phosphoinositide-3 kinase (PI-3 kinase). It remains unclear, however, precisely how this activation occurs and also how the newly generated phospholipid products trigger the various events associated with T cell activation. Here we discuss the current understanding of how PI-3 kinase is activated by the TCR and CD28 and what roles its products play in T cell activation. We also review recent advances in understanding the function of Akt in particular, especially its role in CD28 costimulation. Several functional targets of Akt are discussed in this regard: inducible transcription, cell survival, glucose metabolism, and the cellular translational machinery. These pathways have been associated with TCR/CD28 costimulation, and they have also been implicated as targets of Akt.
引用
收藏
页码:7 / 20
页数:14
相关论文
共 142 条
[1]  
Alberti S, 1998, PROTEINS, V31, P1, DOI 10.1002/(SICI)1097-0134(19980401)31:1<1::AID-PROT1>3.0.CO
[2]  
2-R
[3]   T-cell regulation by CD28 and CTLA-4 [J].
Alegre, ML ;
Frauwirth, KA ;
Thompson, CB .
NATURE REVIEWS IMMUNOLOGY, 2001, 1 (03) :220-228
[4]   Glycogen synthase kinase-3: Properties, functions, and regulation [J].
Ali, A ;
Hoeflich, KP ;
Woodgett, JR .
CHEMICAL REVIEWS, 2001, 101 (08) :2527-2540
[5]   The Akt kinase:: Molecular determinants of oncogenicity [J].
Aoki, M ;
Batista, O ;
Bellacosa, A ;
Tsichlis, P ;
Vogt, PK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) :14950-14955
[6]   CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells [J].
Appleman, LJ ;
van Puijenbroek, AAFL ;
Shu, KM ;
Nadler, LM ;
Boussiotis, VA .
JOURNAL OF IMMUNOLOGY, 2002, 168 (06) :2729-2736
[7]   CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression [J].
Appleman, LJ ;
Berezovskaya, A ;
Grass, I ;
Boussiotis, VA .
JOURNAL OF IMMUNOLOGY, 2000, 164 (01) :144-151
[8]   Pl 3-K and T-cell activation: limitations of T-leukemic cell lines as signaling models [J].
Astoul, E ;
Edmunds, C ;
Cantrell, DA ;
Ward, SG .
TRENDS IN IMMUNOLOGY, 2001, 22 (09) :490-496
[9]   Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3 [J].
Beals, CR ;
Sheridan, CM ;
Turck, CW ;
Gardner, P ;
Crabtree, GR .
SCIENCE, 1997, 275 (5308) :1930-1933
[10]   Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation [J].
Beretta, L ;
Gingras, AC ;
Svitkin, YV ;
Hall, MN ;
Sonenberg, N .
EMBO JOURNAL, 1996, 15 (03) :658-664